Search
Metaraminol
go.drugbank.com/drugs/DB00610ApprovedAn adrenergic agonist that acts predominantly at alpha adrenergic receptors and also stimulates the release of norepinephrine. It has been used primarily as a vasoconstrictor in the treatment of hypotension.
Recombinant stabilized RSV A prefusion F antigen
go.drugbank.com/drugs/DB18713ApprovedInvestigational[L49555] Abrysvo was approved for the same indications in the EU in August 2023[L49565] and Canada in December 2023.
Menthyl salicylate
go.drugbank.com/drugs/DB11201ApprovedMenthyl salicylate is an ester of menthol and salicylic acid . This product is used to treat minor aches and pains of the muscles/joints (e.g., arthritis, backache, sprains) .
Mixtures: Dr. Ds Super 7 Pain ReliefForeskin keratinocyte (neonatal)
go.drugbank.com/drugs/DB10772ApprovedSkin, the largest organ of the human body, plays the main role in protecting the body from mechanical damage. It is composed of epidermal, dermal and hypodermal layers. The barrier function of the skin owed to its avascular epidermal lay...
Asoprisnil ecamate
go.drugbank.com/drugs/DB20225ExperimentalThe usage of the INN stem '-nil' in the name indicates that Asoprisnil ecamate is a benzodiazepine receptor antagonist/agonist. Asoprisnil ecamate has a monoisotopic molecular weight of 520.29 Da.
Elranatamab
go.drugbank.com/drugs/DB15395ApprovedInvestigationalThe resulting 4-chain bispecific antibody is covalently linked via five inter-chain disulfide bonds.
Rosemary oil
go.drugbank.com/drugs/DB14689ApprovedMixtures: Oil, OilSynonyms: Rosemary oil, Oil of rosemarySunflower oil
go.drugbank.com/drugs/DB14329InvestigationalSunflower oil is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Synonyms: Sunflower oil, Sunflower Seed OilBergamot oil
go.drugbank.com/drugs/DB14335InvestigationalBergamot oil is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Synonyms: Bergamot oil, Bergamia OilNaloxegol
go.drugbank.com/drugs/DB09049ApprovedInvestigationalNaloxegol, for "PEGylated naloxol" is a peripherally-selective opioid antagonist developed by AstraZeneca. It was approved by the FDA in September 2014 and is indicated for the treatment of opioid-induced constipation (OIC) in adult pati...